Effects of ferric citrate and intravenous iron sucrose on markers of mineral, bone, and iron homeostasis in a rat model of CKD-MBD
Annabel Biruete, Corinne E. Metzger, Neal X. Chen, Elizabeth A. Swallow et autres
BACKGROUND: Anemia and chronic kidney disease-mineral and bone disorder (CKD-MBD) are common and begin early in CKD. Limited studies have concurrently compared the effects of ferric citrate (FC) versus intravenous (IV) iron on CKD-MBD and iron homeostasis in moderate CKD. METHODS: We …
us (code pays fourni par la source)
9 citations
Nephrology Dialysis Transplantation